Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Alnylam Pharmaceuticals Inc shares valued at $1,633,500 were sold by Garg Pushkal on Mar 24 ’25. At $300.00 per share, Garg Pushkal sold 5,445 shares. The insider’s holdings dropped to 20,221 shares worth approximately $4.58 million following the completion of this transaction.
Also, Garg Pushkal sold 4,321 shares, netting a total of over 1,231,485 in proceeds. Following the sale of shares at $285.00 each, the insider now holds 20,221 shares.
Before that, PYOTT DAVID E I had sold 7,440 shares from its account. In a trade valued at $2,224,560, the Director traded Alnylam Pharmaceuticals Inc shares for $299.00 each. Upon closing the transaction, the insider’s holdings decreased to 7,440 shares, worth approximately $30774.08.
As published in their initiating research note from Redburn Atlantic on March 31, 2025, Alnylam Pharmaceuticals Inc [ALNY] has been a Buy and the price target has been revised to $353. Analysts at JP Morgan upgraded the stock from ‘”a Neutral”‘ to ‘”an Overweight”‘ outlook in a report released in late March. As of November 12, 2024, Wolfe Research has decreased its “Peer perform” rating to a “an Underperform” for ALNY. Earlier on October 16, 2024, Scotiabank initiated its rating. Their recommendation was “a Sector outperform” for ALNY stock.
Analyzing ALNY Stock Performance
During the last five days, there has been a drop of approximately -13.69%. Over the course of the year, Alnylam Pharmaceuticals Inc shares have dropped approximately -3.84%. Shares of the company reached a 52-week high of $300.90 on 03/24/25 and a 52-week low of $205.87 on 04/09/25. A 50-day SMA is recorded $255.81, while a 200-day SMA reached $259.18.
Support And Resistance Levels for Alnylam Pharmaceuticals Inc (ALNY)
According to the 24-hour chart, there is a support level at 215.58, which, if violated, would cause prices to drop to 204.89. In the upper region, resistance lies at 236.15. The next price resistance is at 246.03. RSI (Relative Strength Index) is 39.48 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -25.69, which suggests the price will decrease in the coming days. Percent R is at 78.52%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
